Cooperative Agreement U22PS000541

The federal Project Grant award K23MH136831, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will support a research project to enhance HIV prevention for young men who have sex with men (YMSM). The $364,832 award will be used to develop and evaluate an enhanced care intervention called "HIV Prevention Plus Care (HP+ Care)," which will incorporate motivational interviewing and personalized health education to...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop, pilot, and evaluate a multilevel intervention that combines a refined media campaign and peer-based strategy, informed by social network analysis. The goal is to increase uptake of pre-exposure prophylaxis (PrEP) among young Latino sexual minority men, a population disproportionately impacted by HIV. The award, totaling $186,840,...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $616,742 to the New York Blood Center, Inc. to conduct research on the impact of geographic mobility on pre-exposure prophylaxis (PrEP) and HIV care outcomes among Latino gay, bisexual, and other men who have sex with men (GBMSM) in New York City. The key objectives of this 7-month project are to: 1) Characterize patterns of geographic...

This K23 Mentored Research Career Development Award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will provide $197,035 over 5 years to The General Hospital Corporation (doing business as Massachusetts General Hospital) to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The project aims to: 1) explore the experiences, perceptions,...

This $338,544 Project Grant awarded by the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will support the development and pilot testing of a trauma-informed mHealth and peer support intervention called "BOUNCE." The goal is to promote PrEP (HIV pre-exposure prophylaxis) uptake among gay, bisexual, and other men who have sex with men (MSM), a population disproportionately affected by HIV. The project will...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,260,957 to the Research Foundation of the City University of New York (RFCUNY) to identify preferences and care components for optimizing the delivery of long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) for sexual minority men (SMM) who use methamphetamine. The key products and services to be delivered under this award...

This Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research (CFDA 93.307) program, provides $4,219,628 to Yale University to conduct a pilot waitlist control trial testing a virtual environment as prevention education for Black and Latinx sexual minority men with HIV. The study, titled "LEARN2", aims to utilize formative research to modify the intervention to address social...

This federal Project Grant award of $1,576,238.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to characterize, assess, and protocolize implementation strategies used by community-based organizations to improve the reach of PrEP and mental health/substance use treatments for Latino men who have sex with men (LMSM) in areas with high HIV incidence. The award will leverage a strategic alliance...

This $1,800,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) aims to strengthen sexual health infrastructure and service delivery for priority populations in New York City. The project, led by the New York City Health and Hospitals Corporation (NYCHHC), will expand access to high-quality sexual health services such as HIV testing, STI testing and treatment, vaccinations, and...